Department of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
Hangzhou Mutai Nursing Hospital, Hangzhou, Zhejiang, China (mainland).
Med Sci Monit. 2019 Jun 27;25:4773-4783. doi: 10.12659/MSM.915637.
ABSTRACT Microbial infection is an important cause of acute-on-chronic liver failure (ACLF), which is a syndrome that results in multiple organ dysfunction or failure and is accompanied by an increased short-term risk of mortality. Early detection and treatment of microbial infection can effectively reduce the mortality of patients with ACLF. However, antimicrobial resistance has recently increased due to the increased use of antimicrobial agents. Therefore, it is important to choose appropriate antibiotics and antifungal agents for early prevention or treatment of patients with microbial infection and ACLF to reduce the occurrence of drug resistance and to reduce patient mortality. This review summarizes the current status in the understanding of the epidemiology, pathogenesis, early diagnosis, treatment, and strategies for prevention of microbial infection in patients with ACLF.
摘要 微生物感染是导致慢加急性肝衰竭(ACLF)的重要原因,该综合征会导致多器官功能或衰竭,并伴有短期死亡率增加。早期检测和治疗微生物感染可以有效降低 ACLF 患者的死亡率。然而,由于抗菌药物的使用增加,最近抗菌药物耐药性有所增加。因此,为了减少耐药性的发生和降低患者死亡率,对于微生物感染和 ACLF 的患者,早期预防或治疗时选择合适的抗生素和抗真菌药物非常重要。本综述总结了目前对 ACLF 患者微生物感染的流行病学、发病机制、早期诊断、治疗和预防策略的认识。